Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trial

Julie Hempel Larsen*, Massar Omar, Jesper Jensen, Camilla Fuchs Andersen, Caroline Michaela Kistorp, Mikael Kjær Poulsen, Lars Videbæk, Finn Gustafsson, Lars Køber, Morten Schou, Jacob Eifer Møller

*Corresponding author for this work
1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science